ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for ESOPHAGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Study tests if new feeding tube method improves recovery after esophageal cancer surgery
Disease control CompletedThis study looked at the best way to feed patients after surgery for esophageal cancer. Researchers compared two common feeding tube methods to see if one leads to fewer complications and better recovery. The goal was to help doctors choose the safest and most effective nutrition…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New cancer pill enters human testing for Tough-to-Treat tumors
Disease control CompletedThis first-in-human study tested a new oral drug called JAB-3312 in 40 adults with advanced solid tumors that had progressed despite standard treatments. The main goals were to find the safest dose and see how the body processes the drug. Researchers also looked for early signs t…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope to stop aggressive esophageal Cancer's return
Disease control CompletedThis study tested if adding an immunotherapy drug (pembrolizumab) after standard surgery and chemoradiation could help prevent esophageal cancer from returning in patients at high risk of recurrence. It involved 26 patients in Taiwan who had already undergone initial treatment bu…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
First safety test of new cancer drug for chinese patients
Disease control CompletedThis study tested the safety and how the body processes an experimental drug called SGN-B6A in Chinese patients with advanced solid tumors. It involved a small group of 6 participants who had cancers like lung, head and neck, or stomach cancer that had stopped responding to stand…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Surgical technique tested to reduce dangerous leaks after cancer removal
Disease control CompletedThis study tested if preserving a small artery (the right gastric artery) during a specific type of esophageal cancer surgery leads to fewer complications. It involved 120 patients who were randomly assigned to have the artery either preserved or tied off. The goal was to see if …
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: The First Hospital of Hebei Medical University • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
AI scans could spare cancer patients unnecessary treatment
Diagnosis CompletedThis study looked back at medical records and CT scans from 363 adults with a type of esophageal cancer. Researchers used artificial intelligence to build a computer model. The model's goal is to predict, before surgery, which patients will have no detectable cancer left after re…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Sponsor: Nanjing Medical University • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC
-
Does diabetes sabotage cancer surgery success? major study seeks answers
Knowledge-focused CompletedThis study looked at 605 patients who had surgery for a type of esophageal cancer. Researchers wanted to understand if having type 2 diabetes leads to worse recovery and shorter survival after this surgery. They also investigated whether taking the diabetes drug metformin or havi…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC